Previous studies examined the role of MTCH2 in several types of tumors, including mammary carcinomas (Arigoni et al. 2013; Leibowitz-Amit et al. 2006) and acute myeloid leukemia (AML) (Khan et al. 2020). Here, MTCH2 is linked to acute myeloid leukemia.